Across TCGA pan-cancer cohorts, RPS28P7 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPS28P7’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPS28P7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS28P7 is over-expressed in tumor.

KIRC, LIHC, and ESCA are the cancer types where RPS28P7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS28P7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	III,IV	+0.976	<.001	8	view →
LIHC	Female	III,IV	+1.028	.032	1	view →
ESCA	All	All	+0.959	.022	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RPS28P7 RNA expression & survival · all RPS28P7 data types